Systemic treatment for hepatocellular carcinoma. Aggarwal, M., Arain, A., & Jin, Z. Chronic Diseases and Translational Medicine, September, 2018. 00000
Systemic treatment for hepatocellular carcinoma [link]Paper  doi  abstract   bibtex   
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new promising therapeutic options for these patients. This review article summarizes systemic treatment options evaluated in HCC focusing on the most recently published data and ongoing studies.
@article{aggarwal_systemic_2018,
	title = {Systemic treatment for hepatocellular carcinoma},
	issn = {2095-882X},
	url = {http://www.sciencedirect.com/science/article/pii/S2095882X18300471},
	doi = {10.1016/j.cdtm.2018.08.003},
	abstract = {Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new promising therapeutic options for these patients. This review article summarizes systemic treatment options evaluated in HCC focusing on the most recently published data and ongoing studies.},
	urldate = {2018-09-21},
	journal = {Chronic Diseases and Translational Medicine},
	author = {Aggarwal, Manushi and Arain, Abeer and Jin, Zhao-Hui},
	month = sep,
	year = {2018},
	note = {00000},
	keywords = {Hepatocellular carcinoma, Immunotherapy, Systemic treatment},
}

Downloads: 0